Immunogenes AG in Liquidation
Company Overview
Previous Company Names
- Immunogenes AG
- (Immunogenes SA) (Immunogenes Ltd)
Management
Rainer Knoth
Horw
Liquidator
Individual signing authority
Wolfgang Oster
Lower Gwynedd
Chairperson of the board managing member of the board
Joint signing authority (any two to sign) joint signing authority (any two to sign)
Imre Kacskovics
Budakeszi
Managing member of the board
Joint signing authority (any two to sign)
Gabor Blechta
Henggart
Member of the board
Joint signing authority (any two to sign)
Gábor Komár
Solymár
Member of the board
Joint signing authority (any two to sign)
Christian Schneider
Eching am Ammersee
Member of the board
Joint signing authority (any two to sign)
Zsuzsanna Bősze
Gödöllő
Member of the board
Joint signing authority (any two to sign)
Edit Cserta
Budapest
Member of the board
Joint signing authority (any two to sign)
Beatrice Tschanz Kramel
Zumikon
Member of the board
Joint signing authority (any two to sign)
Lee Schalop
New York
Member of the board
Joint signing authority (any two to sign)
Tonio Barlage
Hamburg
Member of the board
Joint signing authority (any two to sign)
Building smart people network graph...
Fetching people and their companies
Address & Locations
Primary Address
Loading map...
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | 549 | 14.01.2019 | 11 | 17.01.2019 | 1004544057 |
| 2 | 1714 | 09.02.2017 | 31 | 14.02.2017 | 3345551 |
| 3 | 6046 | 09.05.2016 | 91 | 12.05.2016 | 2828551 |
| 4 | 201 | 07.01.2015 | 6 | 12.01.2015 | 1922893 |
| 5 | 10666 | 06.08.2013 | 152 | 09.08.2013 | 1021185 |
| 6 | 4890 | 13.04.2012 | 75 | 18.04.2012 | 6642080 |
| 7 | 1292 | 27.01.2012 | 22 | 01.02.2012 | 6529998 |
| 8 | 12597 | 20.08.2010 | 165 | 26.08.2010 | 18/5785824 |
| 9 | 11051 | 21.07.2010 | 143 | 27.07.2010 | 19/5745832 |
| 10 | 14106 | 19.08.2009 | 163 | 25.08.2009 | 25/5213128 |
Company Purpose
Erwerb, dauernde Verwaltung und Veräusserung von Beteiligungen an in- und ausländischen Unternehmen, insbesondere im Bereich der Immunologie; Kauf, Halten, Administration, Bewirtschaften, Entwicklung, Weiterentwicklung, Verkauf, Lizenzierung und Unterlizenzierung von Immaterialgüterrechten und Technologie und Produktion, Kauf, Vermarktung und Verkauf von Produkten im Bereich der Immunologie und anderen Bereichen der Life Sciences; vollständige Zweckumschreibung gemäss Statuten